GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (MEX:BHC) » Definitions » Long-Term Debt

Bausch Health (MEX:BHC) Long-Term Debt : MXN414,560 Mil (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bausch Health Long-Term Debt?

Bausch Health's Long-Term Debt for the quarter that ended in Sep. 2024 was MXN414,560 Mil.

Bausch Health's quarterly Long-Term Debt increased from Mar. 2024 (MXN357,417 Mil) to Jun. 2024 (MXN388,533 Mil) and increased from Jun. 2024 (MXN388,533 Mil) to Sep. 2024 (MXN414,560 Mil).

Bausch Health's annual Long-Term Debt declined from Dec. 2021 (MXN464,724 Mil) to Dec. 2022 (MXN396,432 Mil) and declined from Dec. 2022 (MXN396,432 Mil) to Dec. 2023 (MXN372,381 Mil).

Bausch Health Long-Term Debt Historical Data

The historical data trend for Bausch Health's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Long-Term Debt Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 465,106.46 475,916.10 464,724.16 396,431.66 372,381.05

Bausch Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 381,369.33 372,381.05 357,416.95 388,532.75 414,559.58

Bausch Health  (MEX:BHC) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Bausch Health Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Bausch Health's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch Health Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (MEX:BHC) » Definitions » Long-Term Debt
Comparable Companies
XCNQ:GTII TSX:CURA XCNQ:TRUL TSX:CRON NEOE:GLAS.A.U NEOE:VRNO TSX:DHT.U TSX:WEED TSX:GUD XCNQ:CL ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS
Traded in Other Exchanges
BHC:USA BVF:Germany BVF:Germany BHC:Canada
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Website
https://www.bauschhealth.com
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.